Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.6.0 to v3.6.2. This denotes a small CMS/page update rather than a substantive change to the study details or content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew sections How to Read a Study Record, Common Questions, and How to Join a Study have been added, and a note indicates no participants are currently being recruited. The Intervention/Treatment header formatting was adjusted and the revision label updated to v3.6.0.SummaryDifference0.4%

- Check22 days agoChange DetectedThe page’s revision history now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This updates the revision record without altering the study details.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page's revision/version label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page version.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page’s footer now shows a newer site “Revision” version (v3.5.3 instead of v3.5.2), indicating a ClinicalTrials.gov site software update.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.